Education
About Us
Working with TipRanks
Follow Us
Keymed Biosciences, Inc. (HK:2162)
:2162
RESEARCH TOOLSreports
Comparison Results
Keymed Biosciences, Inc.
HK$57.25
HK$14.04B
―
79.41%
0 Buy
0 Hold
0 Sell
Moderate Buy
Simcere Pharmaceutical Group Limited
HK$11.94
HK$29.40B
37.56
118.78%
1 Buy
0 Hold
0 Sell
Moderate Buy
CARsgen Therapeutics Holdings Ltd.
HK$24.15
HK$14.31B
―
448.57%
0 Buy
0 Hold
1 Sell
Moderate Sell
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
HK$21.75
HK$8.47B
235.64
189.76%
0 Buy
0 Hold
0 Sell
Hold
Performance Comparison
HK:2162
Keymed Biosciences, Inc.
57.50
25.45
79.41%
HK:1672
Ascletis Pharma, Inc.
11.62
10.54
975.93%
HK:2096
Simcere Pharmaceutical Group Limited
11.88
6.45
118.78%
HK:2157
Lepu Biopharma Co. Ltd. Class H
7.94
5.02
171.92%
HK:2171
CARsgen Therapeutics Holdings Ltd.
24.85
20.32
448.57%
HK:2315
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
21.50
14.08
189.76%